Adverts

Open Access Articles- Top Results for Tedatioxetine

Tedatioxetine

</th></tr>
Tedatioxetine
File:Tedatioxetine.svg
Systematic (IUPAC) name
4-{2-[(4-methylphenyl)sulfanyl]phenyl}piperidine
Clinical data
  • Investigational
Identifiers
508233-95-2 7pxY
None
PubChem CID 9878913
ChemSpider 8054590 7pxY
KEGG D10170 7pxN
Synonyms Lu AA24530; Lu-AA-24530
Chemical data
Formula C18H21NS
283.43 g/mol
 14pxN (what is this?)  (verify)

Tedatioxetine (Lu AA24530) is an antidepressant which is or was under development by Lundbeck and Takeda for the treatment of major depressive disorder (MDD).[1][2] It is reported to act as a triple reuptake inhibitor (5-HT > NE > DA) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist.[3][4][5][6] As of 2009, it was in phase II clinical trials,[6] but there have been no updates since then, and it is no longer displayed on Lundbeck's product pipeline.[1]

See also

References

External links



Lua error in package.lua at line 80: module 'Module:Buffer' not found.